Ann: Final Sofdra Labelling Discussions with FDA, page-126

Read the Euroz Hartleys report (13 may 24) ......says it in there (& I've read elsewhere) - the sale of SOFDRA has a high profit margin BOT have said that themselves. The report mentioned above - also says that.....Sofdra is to sell for around $720 /script GROSS price (to match the competitor being Qbrexxa). It also says that will mean $540/script NET PRICING for sofdra.....to me that means - after ALL/majority of costs involved for SOFDRA....that's what each unit sale is worth to Botanix.
I've posted/mentioned this very recently on HC...simple really. Work your dream on that ($540/script.....maybe even $500/script if you like - WHICH IS AFTER ALL COSTS)......then let us know how it plays out in your calcs!
It is all written/announced previously - not makin this stuff up - I guess the sales & take up will tell. But we also know how that's been panning out so far for Japan don't we!
fuk...I'm just a little bit excited hey..